MEI Pharma

MEI Pharma

MEI Pharma Company(Nasdaq:MEIP)

Sobre MEI Pharma

Fundado

2018

Comunidade

MEI Pharma, Inc.(Nasdaq:MEIP) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Dados de angariação de fundos

Ronda de financiamentoQuantiaValorização
Date
Investidores
Post-IPO
€85.26M
--
2025-07-21
--